• Get 1 Free Meal Delivery from the Food Court

    Login
  • Attend Live Events!

    Login
  • The Inflammation of the Joints Gallery is Now Open!

    Login
  • Explore The Latest Research of 13 Diseases in 5 Unique Galleries

    Login
  • Healthier Healthcare Galleries: Where Discovery Lives

    Login
sAlient Dialogues in PsA
Event

sAlient Dialogues in PsA

Shariar Cohen, MD - sAlient Dialogues in PsA - 7:00 PM (EST)

15-08-2022

Schwartzman - FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis
Event

Schwartzman - FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis

Sergio Schwartzman - FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis - 6:00 PM (EST)

15-08-2022

Real World Evidence Demonstrates the Clinical Effectiveness of Advanced Diagnostics for Lupus
Event

Real World Evidence Demonstrates the Clinical Effectiveness of Advanced Diagnostics for Lupus

Chacko Alappatt, MD - Real World Evidence Demonstrates the Clinical Effectiveness of Advanced Diagnostics for Lupus - 8:00 PM (EST)

15-08-2022

The Treatment of Dermatomyositis and Polymyositis
Event

The Treatment of Dermatomyositis and Polymyositis

Pam Scott, MD - The Treatment of Dermatomyositis and Polymyositis (DMPM) - 7:00 PM (EST)

16-08-2022

Defy Expectations: Challenge Treatment Goals in your Moderate to Severe RA Adult TNFi-IR Patients
Event

Defy Expectations: Challenge Treatment Goals in your Moderate to Severe RA Adult TNFi-IR Patients

Dhiman Basu, MD - Defy Expectations: Challenge Treatment Goals in your Moderate to Severe RA Adult TNFi-IR Patients - 6:00 PM (EST)

16-08-2022

Inform treatment decisions & improve care for patients with rheumatoid arthritis with PrismRA
Event

Inform treatment decisions & improve care for patients with rheumatoid arthritis with PrismRA

Robert Holmes, MD - Inform treatment decisions & improve care for patients with rheumatoid arthritis with PrismRA - 8:00 PM (EST)

16-08-2022

The Current State of OFEV in Chronic Interstitial Lung Diseases with a Progressive Phenotype
Event

The Current State of OFEV in Chronic Interstitial Lung Diseases with a Progressive Phenotype

Ayodeji Adegunsoye, MD - The Current State of OFEV in Chronic Interstitial Lung Diseases with a Progressive Phenotype - 8:00 PM (EST)

17-08-2022

Managing Remission in Patients With Moderate to Severe RA: Results From Multiple Studies, Including SEAM-RA
Event

Managing Remission in Patients With Moderate to Severe RA: Results From Multiple Studies, Including SEAM-RA

Carl Gauthier - Managing Remission in Patients With Moderate to Severe RA: Results From Multiple Studies, Including SEAM-RA - 8:00 PM (EST)

17-08-2022

Treat PsA From The Start: Consider Otezla For Patients Who Need More Than An NSAID
Event

Treat PsA From The Start: Consider Otezla For Patients Who Need More Than An NSAID

Kostas Botsoglou, MD - Treat PsA From The Start: Consider Otezla For Patients Who Need More Than An NSAID - 6:00 PM (EST)

17-08-2022

The First and Only FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis
Event

The First and Only FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis

Sanjay Chabra, MD - CIMZIA (certolizumab pegol) The First and Only FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis - 7:00 PM (EST)

18-08-2022

Clinical Data for an Oral Prescription Treatment Option for Adults With Active Ankylosing Spondylitis
Event

Clinical Data for an Oral Prescription Treatment Option for Adults With Active Ankylosing Spondylitis

Phillip Mease, MD - Exploring the Clinical Data for an Oral Prescription Treatment Option for Adults With Active Ankylosing Spondylitis - 8:00 PM (EST)

18-08-2022

Real World Evidence Demonstrates the Clinical Effectiveness of Advanced Diagnostics for Lupus
Event

Real World Evidence Demonstrates the Clinical Effectiveness of Advanced Diagnostics for Lupus

Robert Levin, MD - Real World Evidence Demonstrates the Clinical Effectiveness of Advanced Diagnostics for Lupus - 8:00 PM (EST)

18-08-2022

Dhiman Basu Clinical Experiences in RA
Event

Dhiman Basu Clinical Experiences in RA

Dhiman Basu, MD - Clinical Experiences in RA - 8:00 PM (EST)

21-08-2022

Clinical Program for an Approved JAK Inhibitor in Patients With Moderate to Severe Rheumatoid Arthritis
Event

Clinical Program for an Approved JAK Inhibitor in Patients With Moderate to Severe Rheumatoid Arthritis

Ekaterini Zapantis, MD - Review of the Clinical Program for an Approved JAK Inhibitor in Patients With Moderate to Severe Rheumatoid Arthritis - 7:00 PM (EST)

21-08-2022

Grace Wright - The First and Only FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis
Event

Grace Wright - The First and Only FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis

Grace Wright, MD - CIMZIA (certolizumab pegol) The First and Only FDA-approved TNF Inhibitor for Non-radiographic Axial Spondyloarthritis - 7:00 PM (EST)

20-09-2022

Alvin Wells Targeting Lupus Nephritis
Event

Alvin Wells Targeting Lupus Nephritis

Alvin Wells, MD - Targeting Lupus Nephritis - 8:00 PM (EST)

21-09-2022

Frank Wellborne sAlient Dialogues in PsA
Event

Frank Wellborne sAlient Dialogues in PsA

Frank Wellborne, MD - sAlient Dialogues in PsA - 6:00 PM (EST)

21-09-2022

Dr. Howard Busch, DO - Treatment of Symptomatic Sarcoidosis
Event

Dr. Howard Busch, DO - Treatment of Symptomatic Sarcoidosis

Dr. Howard Busch, DO - Treatment of Symptomatic Sarcoidosis - 7:00 PM (EST)

22-09-2022

Robert Schoen, MD - sAlient Dialogues in PsA
Event

Robert Schoen, MD - sAlient Dialogues in PsA

Robert Schoen, MD - sAlient Dialogues in PsA - 6:00 PM (EST)

25-10-2022